Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Epidemiologic and Socioeconomic Status of Bladder Cancer in Mazandaran province, Northern Iran

  • Published : 2012.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Bladder cancer is one the most common malignancies of the genitourinary tract. The present study aimed to assess the epidemiology, of bladder cancer in Mazandaran, a large province in northern Iran as high-incidence cancer area, during a 2-year period. Methods: The data for this study were obtained from the population-based cancer registry of the Vice-Chancellory for Health Affairs of Mazandaran University of Medical Sciences and Mazandaran hospitals between March 1, 2010 and March 1, 2011. Demographic data, including sex, age, residency and symptoms were investigated through careful review of medical records. Using a questionnaire protocol, several variables were assessed for these cases such as smoking, history of opium, vegetable consumption habits, and history of other cancers. Results: A total of 112 cases were analyzed, 98 (87.5%) in men and 14 (12.5%) in women (mean age of $68.0{\pm}14.6$ years). Urban and rural residence were 60.7% and 39.3%. Tobacco and opium use were found in 45.5% and 21.4% of patients, respectively. Approximately 60% consumed vegetables an average of fewer than one time per day. Hematuria was the first symptom in these cases which were mainly diagnosed as having bladder cancer by ultrasonography. Conclusion: The results showed that bladder cancer tends to be found in the elderly and the male to female ratio is high. Macroscopic hematuria is a very important symptom for indicating probably urothelial tumor that should be followed up patients with transabdominal ultrasonography as a routine modality.

Keywords

References

  1. Aben KK, Witjes JA, Schoenberg MP, et al (2002). Familial aggregation of urothelial cell carcinoma. Int J Cancer, 98, 274-8. https://doi.org/10.1002/ijc.10191
  2. Ahmad E, Ghasemkhani O, Dastoori P (2003). Recurrence rate and prognostic factors of superficial bladder cancer in shiraz shahid faghihi hospital during the years 1998-2001. J Zanjan Univ Med Sci, 11, 7-1. (Persian)
  3. Anderson B, Naish W (2008). Bladder cancer and smoking. Part 1: addressing the associated risk factors. Br J Nurs, 17, 1182-6.
  4. Asgari MA, Kaviani A, Gachkar L, Hosseini Nasab SR (2004). Is bladder cancer more common among opium addicts? Urol J, 1, 253-5.
  5. Badar F, Sattar A, Meerza F, Irfan N, Siddiqui N (2009). Carcinoma of the urinary bladder in a tertiary care setting in a developing country. Asian Pac J Cancer Prev, 10, 449-52.
  6. Bedwani R, el-Khwsky F, Renganathan E, et al (1997). Epidemiology of bladder cancer in Alexandria, Egypt: tobacco smoking. Int J Cancer, 73, 64-7. https://doi.org/10.1002/(SICI)1097-0215(19970926)73:1<64::AID-IJC11>3.0.CO;2-5
  7. Behmard S, Sadeghi A, Mohareri MR, Kadivar R (1981). Positive association of opium addiction and cancer of the bladder. Results of urine cytology in 3,500 opium addicts. Acta Cytol, 25, 142-6.
  8. Ben-Kasus T, Ben-Zvi Z, Marquez VE, Kelley JA, Agbaria R (2005). Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells. Biochem Pharmacol, 70, 121-33. https://doi.org/10.1016/j.bcp.2005.04.010
  9. Carel R, Levitas-Langman A, Kordysh E, Goldsmith J, Friger M (1999). Case-referent study on occupational risk factors for bladder cancer in southern Israel. Int Arch Occup Environ Hlth, 72, 304-8. https://doi.org/10.1007/s004200050379
  10. Dibb MJ, Noble DJ, Peh WC, et al (2001). Ultrasonographic analysis of bladder tumors. Clin Imaging, 25, 416-20. https://doi.org/10.1016/S0899-7071(01)00304-7
  11. Fajkovic H, Halpern JA, Cha EK, et al (2011). Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol, 29, 457-63. https://doi.org/10.1007/s00345-011-0709-9
  12. Farahmand M, Khademolhosseini F, Medhati M, et al (2009). Trend of bladder cancer in fars province, Southern Iran, 2002-2006. Iran Red Cres Med J, 11, 470-2.
  13. Gore JL, Lai J, Setodji CM, Litwin MS, Saigal CS (2009). Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a surveillance, epidemiology, and end results-medicare nalysis. Cancer, 115, 988-96. https://doi.org/10.1002/cncr.24052
  14. Hosseini SY, Safarinejad MR, Amini E, Hooshyar H (2010). Opium consumption and risk of bladder cancer: A casecontrol analysis. Urol Oncol, 28, 610-6. https://doi.org/10.1016/j.urolonc.2008.10.016
  15. Jankovic S, Radosavljevic V (2007). Risk factors for bladder cancer. Tumori, 93, 4-12.
  16. Johansson SL, Cohen SM (1997). Epidemiology and etiology of bladder cancer. Semin Surg Oncol, 13, 291-8. https://doi.org/10.1002/(SICI)1098-2388(199709/10)13:5<291::AID-SSU2>3.0.CO;2-8
  17. Johnson EK, Daignault S, Zhang Y, Lee CT (2008). Patterns of hematuria referral to urologists: does a gender disparity exist? Urology, 72, 498-502. https://doi.org/10.1016/j.urology.2008.01.086
  18. Kirkali Z, Chan T, Manoharan M, et al (2005). Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology, 66, 4-34. https://doi.org/10.1016/S0090-4295(05)00945-3
  19. La Vecchia C, Negri E (1996). Nutrition and bladder cancer. Cancer Causes Control, 7, 95-100. https://doi.org/10.1007/BF00115641
  20. Lagwinski N, Thomas A, Stephenson AJ, et al (2007). Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases. Am J Surg Pathol, 31, 1777-87. https://doi.org/10.1097/PAS.0b013e31805c9cd9
  21. Lynch CF, Cohen MB (1995). Urinary system. Cancer, 75, 316-29. https://doi.org/10.1002/1097-0142(19950101)75:1+<316::AID-CNCR2820751314>3.0.CO;2-T
  22. Malone PR (1989). Transabdominal ultrasound surveillance for bladder cancer. Urol Clin North Am, 16, 823-7.
  23. Murta-Nascimento C, Schmitz-Dräger BJ, Zeegers MP, et al (2007). Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol, 25, 285-95. https://doi.org/10.1007/s00345-007-0168-5
  24. Negri E, La Vecchia C (2001). Epidemiology and prevention of bladder cancer. Eur J Cancer Prev, 10, 7-14. https://doi.org/10.1097/00008469-200102000-00002
  25. Nielsen ME, Palapattu GS, Karakiewicz PI, et al (2007). A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome. BJU Int, 100, 15-20. https://doi.org/10.1111/j.1464-410X.2007.06946.x
  26. Oberfield RA, Zinman LN, Leibenhaut M, Girshovich L, Silverman ML (1996). Management of invasive squamous cell carcinoma of the bulbomembranous male urethra with co-ordinated chemo-radiotherapy and genital preservation. Br J Urol, 78, 573-8. https://doi.org/10.1046/j.1464-410X.1996.17014.x
  27. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
  28. Radosavljevic V, Jankovic S, Marinkovic J, Dokic M (2004). Non-occupational risk factors for bladder cancer: a casecontrol study. Tumori, 90, 175-80.
  29. Salehi A, Khezri AA, Malekmakan L, Aminsharifi A (2011). Epidemiologic status of bladder cancer in Shiraz, southern Iran. Asian Pac J Cancer Prev, 12, 1323-7.
  30. Samanic C, Kogevinas M, Dosemeci M, et al (2006). Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiol Biomarkers Prev, 15, 1348-54. https://doi.org/10.1158/1055-9965.EPI-06-0021
  31. Scelo G, Brennan P (2007). The epidemiology of bladder and kidney cancer. Nat Clin Pract Urol, 4, 205-217. https://doi.org/10.1038/ncpuro0760
  32. Schottenfeld D, Beebe-Dimmer J (2006). Alleviating the burden of cancer: a perspective on advances, challenges, and future directions. Cancer Epidemiol Biomarkers Prev, 15, 2049-55. https://doi.org/10.1158/1055-9965.EPI-06-0603
  33. Shakhssalim N, Hosseini SY, Basiri A, et al (2010). Prominent bladder cancer risk factors in Iran. Asian Pac J Cancer Prev, 11, 601-6.
  34. Steinmaus CM, Nunez S, Smith AH (2000). Diet and bladder cancer: a meta-analysis of six dietary variables. Am J Epidemiol, 151, 693-702. https://doi.org/10.1093/oxfordjournals.aje.a010264
  35. Yamada T, Tsuchiya K, Kato S, et al (2010). A pretreatment nomogram predicting recurrence- and progression-free survival for nonmuscle invasive bladder cancer in Japanese patients. Int J Clin Oncol, 15, 271-9. https://doi.org/10.1007/s10147-010-0049-6
  36. Yavari P, Sadrolhefazi B, Mohagheghi MA, Mehrazin R (2009). A descriptive retrospective study of bladder cancer at a hospital in Iran (1973-2003). Asian Pac J Cancer Prev, 10, 681-4.
  37. Yip SK, Peh WC, Tam PC, Li JH, Lam CH (1998). Day case hematuria diagnostic service: use of ultrasonography and flexible cystoscopy. Urology, 52, 762-6. https://doi.org/10.1016/S0090-4295(98)00325-2
  38. Zeegers MP, Kellen E, Buntinx F, van den Brandt PA (2004). The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol, 21, 392-401. https://doi.org/10.1007/s00345-003-0382-8

Cited by

  1. Age at Diagnosis in Bladder Cancer: Does Opium Addiction Play a Role? vol.14, pp.8, 2013, https://doi.org/10.7314/APJCP.2013.14.8.4723
  2. Mortality of Urinary Tract Cancer in Inner Mongolia 2008-2012 vol.15, pp.6, 2014, https://doi.org/10.7314/APJCP.2014.15.6.2831
  3. Are Bladder Neoplasms More Aggresive in Patients with a Smoking-related Second Malignancy? vol.15, pp.9, 2014, https://doi.org/10.7314/APJCP.2014.15.9.4025
  4. Demographic Survey of Four Thousand Patients with 10 Common Cancers in North Eastern Iran over the Past Three Decades vol.15, pp.23, 2014, https://doi.org/10.7314/APJCP.2014.15.23.10193
  5. Incidence and Mortality of Bladder Cancer and their Relationship with Development in Asia vol.16, pp.16, 2015, https://doi.org/10.7314/APJCP.2015.16.16.7365
  6. Opium and bladder cancer: A systematic review and meta-analysis of the odds ratios for opium use and the risk of bladder cancer vol.12, pp.6, 2017, https://doi.org/10.1371/journal.pone.0178527
  7. Health risk assessment induced by chloroform content of the drinking water in Iran: systematic review vol.36, pp.4, 2017, https://doi.org/10.1080/15569543.2017.1370601